SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism
- PMID: 20976535
- PMCID: PMC7088804
- DOI: 10.1007/s11262-010-0544-x
SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) encodes a highly basic nucleocapsid (N) protein which can inhibit the synthesis of type I interferon (IFN), but the molecular mechanism of this antagonism remains to be identified. In this study, we demonstrated that the N protein of SARS-CoV could inhibit IFN-beta (IFN-β) induced by poly(I:C) or Sendai virus. However, we found that N protein could not inhibit IFN-β production induced by overexpression of downstream signaling molecules of two important IFN-β induction pathways, toll-like receptor 3 (TLR3)- and RIG-I-like receptors (RLR)-dependent pathways. These results indicate that SARS-CoV N protein targets the initial step, probably the cellular PRRs (pattern recognition receptors)-RNAs-recognition step in the innate immune pathways, to suppress IFN expression responses. In addition, co-immunoprecipitation assays revealed that N protein did not interact with RIG-I or MDA5. Further, an assay using truncated mutants revealed that the C-terminal domain of N protein was critical for its antagonism of IFN induction, and the N deletion mutant impaired for RNA-binding almost completely lost the IFN-β antagonist activity. These results contribute to our further understanding of the pathogenesis of SARS-CoV.
Figures
Similar articles
-
SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.J Med Virol. 2021 Sep;93(9):5376-5389. doi: 10.1002/jmv.27050. Epub 2021 May 9. J Med Virol. 2021. PMID: 33913550 Free PMC article.
-
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production.Viruses. 2020 Dec 30;13(1):47. doi: 10.3390/v13010047. Viruses. 2020. PMID: 33396605 Free PMC article.
-
Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.J Virol. 2020 Jun 16;94(13):e00099-20. doi: 10.1128/JVI.00099-20. Print 2020 Jun 16. J Virol. 2020. PMID: 32295922 Free PMC article.
-
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon.Curr Opin Virol. 2012 Jun;2(3):264-75. doi: 10.1016/j.coviro.2012.04.004. Epub 2012 May 7. Curr Opin Virol. 2012. PMID: 22572391 Free PMC article. Review.
-
Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.J Gen Virol. 2010 Aug;91(Pt 8):2080-2090. doi: 10.1099/vir.0.020552-0. Epub 2010 Apr 7. J Gen Virol. 2010. PMID: 20375222
Cited by
-
Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.Int J Mol Sci. 2024 Mar 16;25(6):3378. doi: 10.3390/ijms25063378. Int J Mol Sci. 2024. PMID: 38542351 Free PMC article.
-
Multiple Lines of Evidence Support 199 SARS-CoV-2 Positively Selected Amino Acid Sites.Int J Mol Sci. 2024 Feb 19;25(4):2428. doi: 10.3390/ijms25042428. Int J Mol Sci. 2024. PMID: 38397104 Free PMC article.
-
Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development.Brain Sci. 2024 Jan 6;14(1):59. doi: 10.3390/brainsci14010059. Brain Sci. 2024. PMID: 38248274 Free PMC article. Review.
-
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.Signal Transduct Target Ther. 2023 Jun 7;8(1):237. doi: 10.1038/s41392-023-01510-8. Signal Transduct Target Ther. 2023. PMID: 37286535 Free PMC article. Review.
-
Molecular mechanisms of human coronavirus NL63 infection and replication.Virus Res. 2023 Apr 2;327:199078. doi: 10.1016/j.virusres.2023.199078. Epub 2023 Feb 22. Virus Res. 2023. PMID: 36813239 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous